Epidemiology of respiratory syncytial virus and its subtypes among cases of influenza like illness and severe acute respiratory infection: findings from nationwide sentinel surveillance in Ethiopia
- PMID: 40707913
- PMCID: PMC12291252
- DOI: 10.1186/s12879-025-11330-6
Epidemiology of respiratory syncytial virus and its subtypes among cases of influenza like illness and severe acute respiratory infection: findings from nationwide sentinel surveillance in Ethiopia
Abstract
Background: Data in Ethiopia on the epidemiology of Respiratory Syncytial Virus (RSV) and subtypes among influenza-like illness (ILI) and severe acute respiratory infections (SARI) cases is limited. Here, we assessed the epidemiology of RSV and its subtypes among the pediatric and adult ILI /SARI cases in Ethiopia.
Methods: We conducted prospective, multicenter facility-based study from May 2023 to April 2024. Respiratory swab specimens, epidemiological and clinical data were collected from participants of all age groups, and both hospitalized and non-hospitalized individuals who met the World Health Organization (WHO) case definition for ILI/SARI and provided informed consent. Laboratory investigation was performed using reverse transcription polymerase chain reaction (RT-PCR). Data were analyzed using SPSS V29. Descriptive statistics were used to summarize frequencies and ratios, and multivariable logistic regression model was employed to assess factors associated with RSV positivity.
Results: In total, 4170 participants were enrolled, the majority (57.9%) of whom were cases from children under five and SARI (76.5%). RSV was detected in 654 cases (15.7%; 95% CI: 14.6-16.8). RSV subtyping was carried out for 475 (72.6%) of 654 RSV positive samples. The finding revealed that both RSV-A and RSV-B subtypes were co-circulating in Ethiopia, with predominance of RSV-B (68.8%). Age group, season and timing of sample collection were factors independently associated with RSV positivity. Accordingly, children aged < 2 years (AOR: 8.20, 95% CI: 3.57-18.81) and 2-4 years (AOR: 5.01, 95% CI: 2.15-11.67), autumn (AOR: 5.89, 95% CI: 3.79-9.17) and winter (AOR: 3.27, 95% CI: 2.07-5.16) seasons, and case whose samples were collected within three days of symptom onset (AOR: 1.76, 95% CI: 1.09-2.84) were significantly associated with RSV positivity.
Conclusions: The study provides evidence of RSV circulation among ILI/SARI cases in Ethiopia. It also revealed that RSV-B was the predominant subtype circulating in the country. The age-specific and temporal patterns of RSV positivity identified in this study contribute to the understanding of RSV and its subtypes epidemiology in Ethiopia. The findings provide valuable evidence to inform implementation of RSV vaccine introduction programs, particularly targeting high-risk populations during periods of peak transmission. Future research focusing on RSV genomic analysis and disease burden is needed to better understand RSV viral evolution, transmission dynamics and public health impacts in Ethiopia.
Keywords: Epidemiology; Ethiopia; ILI/SARI; RSV; RSV subtypes; RT-PCR.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was conducted in accordance with ethical standards of the Declaration of Helsinki for medical research involving human subjects. Ethical approval was obtained from the Research and Ethical Review Committee of Addis Ababa University, Aklilu Lemma Institute of Pathobiology (Ref. No: ALIPB IRERC/110/2015/23) and the Institutional Review Board of Ethiopian Public Health Institute (Protocol No: EPHI-IRB-511-2023). Appropriate training was provided to data and sample collectors and study participants were recruited only after informed consent was obtained from the participants themselves, or from parents, guardians, or caregivers of children under the age of 18 years. Additionally, an assent was obtained for children between 12 and 17 years of age. Confidentiality of the data was maintained throughout the study using unique and anonymous identifier. Test results were shared back to health facilities and regions to support proper case management and surveillance efforts. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures

Similar articles
-
Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico.Influenza Other Respir Viruses. 2017 Jan;11(1):48-56. doi: 10.1111/irv.12414. Epub 2016 Aug 18. Influenza Other Respir Viruses. 2017. PMID: 27439650 Free PMC article.
-
Epidemiology of Respiratory Syncytial Virus in Adults and Children With Medically Attended Acute Respiratory Illness Over Three Seasons.Clin Infect Dis. 2024 Oct 15;79(4):1039-1045. doi: 10.1093/cid/ciae303. Clin Infect Dis. 2024. PMID: 38836601 Free PMC article.
-
Shifts in Influenza and Respiratory Syncytial Virus Infection Patterns in Korea After the COVID-19 Pandemic Resulting From Immunity Debt: Retrospective Observational Study.JMIR Public Health Surveill. 2025 Jul 23;11:e68058. doi: 10.2196/68058. JMIR Public Health Surveill. 2025. PMID: 40700345 Free PMC article.
-
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6. Cochrane Database Syst Rev. 2023. PMID: 36715243 Free PMC article.
-
Trends in Proportions of Respiratory Syncytial Virus Infections Among Reported Respiratory Tract Infection Cases in Children Aged 0 to 5 Years in Western Pacific and Southeast Asia Regions: A Systematic Review and Meta-Analysis.Influenza Other Respir Viruses. 2025 Feb;19(2):e70077. doi: 10.1111/irv.70077. Influenza Other Respir Viruses. 2025. PMID: 39921537 Free PMC article.
References
-
- CDC. Respiratory Syncytial Virus Infection (RSV). 2024. Available from: https://www.cdc.gov/rsv/about/index.html. Cited 2024 Oct 15.
-
- Shi T, McAllister DA, O’Brien KL, Simoes EAF, Madhi SA, Gessner BD et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946–58. Available from:https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(17)30938-8.pdf. - PMC - PubMed
-
- Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and National disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047–64. - PMC - PubMed
-
- Calaor-Morin J, Arguelles VL, Foronda JL, Tan A, Lagamayo E, Dapat C, et al. Genotyping of respiratory syncytial virus among influenza-like illness and severe acute respiratory infection cases of children in the Philippines from 2006 to 2016. Influenza Other Respi Viruses. 2022;16:942–51. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous